NTLA Competitors & Alternatives
Compare Intellia Therapeutics Inc with similar stocks in the same industry
Biotechnology
NTLA
Main Stock$15.75
Tradestie Score
56
Market Cap
$2.01B
Revenue Growth
-0.1%
Analyst Upside
+69.1%
Top Competitors
222 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ARQT
Arcutis Biotherapeutics, Inc. Common Stock
|
$26.66
|
$2.37B | - | 56 | Compare |
|
APGE
Apogee Therapeutics, Inc. Common Stock
|
$132.55
|
$2.35B | - | 66 | Compare |
|
IBRX
ImmunityBio, Inc. Common Stock
|
$7.22
|
$2.34B | - | 52 | Compare |
|
IRON
Disc Medicine, Inc. Common Stock
|
$70.80
|
$2.33B | - | 61 | Compare |
|
AGIO
Agios Pharmaceuticals, Inc.
|
$35.10
|
$2.33B | - | 54 | Compare |
|
GLPG
Galapagos NV
|
$27.73
|
$2.31B | 5.1 | 59 | Compare |
|
RXRX
Recursion Pharmaceuticals, Inc. Class A Common Stock
|
$3.18
|
$2.23B | - | 49 | Compare |
|
ADPT
Adaptive Biotechnologies Corporation Common Stock
|
$17.37
|
$2.22B | - | 59 | Compare |
|
TVTX
Travere Therapeutics, Inc. Common Stock
|
$55.11
|
$2.21B | - | 64 | Compare |
|
DNLI
Denali Therapeutics Inc. Common Stock
|
$24.05
|
$2.18B | - | 67 | Compare |
More NTLA Analysis
Data updated: Jun 23, 2026 | Industry: Biotechnology (SIC 2835)
222 stocks in this industry